Prognostic Value of hs-CRP After Transcatheter Aortic Valve Implantation

Circ Cardiovasc Interv. 2018 Dec;11(12):e007213. doi: 10.1161/CIRCINTERVENTIONS.118.007213.

Authors

Diego Iglesias-Álvarez^{1

2}, Diego López-Otero^{1

2}, Rocío González-Ferreiro³, Xoan Sanmartín-Pena^{1

2}, Belén Cid-Álvarez^{1

2}, Ramiro Trillo-Nouche^{1

2}, José Ramón González-Juanatey^{1

2}

Affiliations

¹ Department of Cardiology, Complexo Hospitalario Universitario de Santiago, Spain (D.I.-A., D,L.-O., X.S.-P., B.C.-A., R.T.-N., J.R.G.-J.).
² CIBERCV (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares), Santiago de Compostela, Spain (D.I.-A., D,L.-O., X.S.-P., B.C.-A., R.T.-N., J.R.G.-J.).
³ Department of Cardiology, Complejo Asistencial Universitario de Salamanca, Spain (R.G.-F.).

PMID: 30562090
DOI: 10.1161/CIRCINTERVENTIONS.118.007213

No abstract available

Keywords: C-reactive protein; aortic valve; inflammation; prognosis; transcatheter aortic valve implantation.

Publication types

Letter
Observational Study

MeSH terms

Aortic Valve Stenosis / blood
Aortic Valve Stenosis / diagnosis
Aortic Valve Stenosis / mortality
Aortic Valve Stenosis / surgery*
Biomarkers / blood
C-Reactive Protein / metabolism*
Humans
Inflammation Mediators / blood*
Predictive Value of Tests
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Transcatheter Aortic Valve Replacement* / adverse effects
Transcatheter Aortic Valve Replacement* / mortality
Treatment Outcome

Substances

Biomarkers
Inflammation Mediators
C-Reactive Protein